NCT00721825

Study of NeuroAid In Enhancing Recovery After Stroke

A Double-Blinded, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of a Traditional Chinese Medicine NeuroAid In Enhancing Recovery After Stroke (TIERS)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Moleac Pte Ltd. · Industry
• Sex: All
• Age: 21 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

TIERS is a phase II to generate detailed preliminary data on the efficacy of NeuroAid in post-stroke recovery, and to assess the utility of the rehabilitation outcome measure instruments used.

Conditions

• Stroke
• Cerebral Infarction

Interventions

Type	Name	Description
DRUG	Neuroaid	Neuroaid capsules, 4 capsules, three times per day, during one month
DRUG	Neuroaid matched Placebo	Neuroaid matched placebo 4 capsules three times per day during one month

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2008-07-24
• Last updated: 2008-07-24

Locations

1 site across 1 country: Singapore